These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20516025)

  • 1. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
    Chung CP; Oeser A; Raggi P; Sokka T; Pincus T; Solus JF; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2010 Aug; 37(8):1633-8. PubMed ID: 20516025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus.
    Chung CP; Oeser A; Raggi P; Solus JF; Avalos I; Linton MF; Fazio S; Stein CM
    Clin Rheumatol; 2008 Oct; 27(10):1227-33. PubMed ID: 18421545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
    Knowlton N; Wages JA; Centola MB; Giles J; Bathon J; Quiroga C; Alaupovic P
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):993-1000. PubMed ID: 22337612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
    Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
    Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Associations of Low Circulating Low-Density Lipoprotein Concentration With Subclinical Coronary Atherosclerosis.
    Giles JT; Wasko MCM; Chung CP; Szklo M; Blumenthal RS; Kao A; Bokhari S; Zartoshti A; Stein CM; Bathon JM
    Arthritis Rheumatol; 2019 Sep; 71(9):1426-1436. PubMed ID: 30883031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.
    Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
    Scand J Rheumatol; 2009; 38(3):184-9. PubMed ID: 19165647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein particle number predicts coronary artery calcification in asymptomatic adults at intermediate risk of cardiovascular disease.
    Prado KB; Shugg S; Backstrand JR
    J Clin Lipidol; 2011; 5(5):408-13. PubMed ID: 21981843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease.
    Williams PT; Zhao XQ; Marcovina SM; Otvos JD; Brown BG; Krauss RM
    Atherosclerosis; 2014 Apr; 233(2):713-720. PubMed ID: 24603218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals.
    Aneni EC; Osondu CU; De La Cruz J; Martin SS; Blaha MJ; Younus A; Feldman T; Agatston AS; Veledar E; Nasir K
    J Atheroscler Thromb; 2019 Jan; 26(1):50-63. PubMed ID: 30224606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
    Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
    Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Coronary Calcium, Carotid Wall Thickness, and Carotid Plaque Progression With Low-Density Lipoprotein and High-Density Lipoprotein Particle Concentration Measured by Ion Mobility (From Multiethnic Study of Atherosclerosis [MESA]).
    Ceponiene I; Li D; El Khoudary SR; Nakanishi R; Stein JH; Wong ND; Nezarat N; Kanisawa M; Rahmani S; Osawa K; Tattersall MC; Budoff MJ
    Am J Cardiol; 2021 Mar; 142():52-58. PubMed ID: 33278360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.